CLEVELAND, Nov. 8 /PRNewswire-FirstCall/ -- DATATRAK International, Inc. (Nasdaq: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today reported its operating results for the third quarter and first nine months of 2007.
For the three months ended September 30, 2007, revenue decreased 52% to $2,116,000, and the Company reported a net loss of $(3,506,000), or $(0.26) per share on a basic and diluted basis. These results compared with revenue of $4,374,000, and a net loss of $(1,326,000), or $(0.12) per share basic and diluted basis, in the third quarter of 2006.
For the nine months ended September 30, 2007, DATATRAK's revenue decreased 36% to $8,723,000, and a net loss of $(8,367,000), or $(0.64) per share on a basic and diluted basis was recorded for the period. The Company reported revenue of $13,705,000, and a net loss of $(2,109,000), or $(0.19) per share basic and diluted basis, in the corresponding period of the previous year.
During the three months ended September 30, 2007, the Company recorded an impairment charge of $213,000 against its non-compete intangible asset acquired from ClickFind.
DATATRAK recorded severance charges totaling $386,000 in the third
quarter of 2007 associated with the net reduction of 11 employees. The
employee reductions are expected to decrease annual direct costs by
approximately $280,000 and annual SG&A expenses by approximately $520,000,
for a total cost reduction of approximately $800,000 per year. Coupled with
the 17 employee reductions from earlier in the year, annual direct costs
are expected to decrease by approximately $795,000 and annual SG&A expenses
are expected to decrease by approxima
|SOURCE DATATRAK International, Inc.|
Copyright©2007 PR Newswire.
All rights reserved